Quality of life after lacunar stroke: the Secondary Prevention of Small Subcortical Strokes study

J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):1131-7. doi: 10.1016/j.jstrokecerebrovasdis.2013.09.029. Epub 2013 Oct 28.

Abstract

Background: We sought to describe the course and predictors of quality of life (QOL) after lacunar stroke. We hypothesized that there is a decline in QOL after recovery from lacunar stroke.

Methods: The Secondary Prevention of Small Subcortical Strokes is a clinical trial in lacunar stroke patients with annual assessments of QOL with the stroke-specific QOL score. The overall score was used and analyzed as a continuous variable (range 0-5). We fit linear mixed models to assess the trend in QOL over time, assuming linearity of time, and adjusted for demographics, medical risk factors, cognitive factors, and functional status in univariable and multivariable models.

Results: Among 2870 participants, mean age was 63.4 years (SD 10.7), 63% were men, 51% White, 32% Hispanic, 36% had college education, 36% had diabetes, 89% had hypertension, and 10% had prior stroke. Mean poststroke Barthel Index (BI) score was 95.4 (assessed on average 6 months after stroke). In the final multivariable model, there was an average increase in QOL of .6% per year, and factors associated with decline in QOL over time included age (-.0003 per year, P < .0001), any college education (-.0013 per year, .01), prior stroke (-.004 per year, P < .0001), and BI (-.0002 per year, P < .0001).

Conclusions: In this clinical trial of lacunar stroke patients, there was a slight annual increase in QOL overall, and age, level of education, and prior stroke were associated with changes in QOL over time. Multiple strokes may cause decline in QOL over time in the absence of recurrent events.

Trial registration: ClinicalTrials.gov NCT00059306.

Keywords: Lacunar stroke; disability; quality of life; recovery.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Age Factors
  • Aged
  • Antihypertensive Agents / therapeutic use*
  • Comorbidity
  • Disability Evaluation
  • Double-Blind Method
  • Drug Therapy, Combination
  • Educational Status
  • Female
  • Humans
  • Linear Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Prospective Studies
  • Quality of Life*
  • Recurrence
  • Risk Factors
  • Secondary Prevention / methods*
  • Stroke, Lacunar / diagnosis
  • Stroke, Lacunar / drug therapy*
  • Stroke, Lacunar / physiopathology
  • Stroke, Lacunar / psychology
  • Time Factors
  • Treatment Outcome
  • United States

Substances

  • Antihypertensive Agents
  • Platelet Aggregation Inhibitors

Associated data

  • ClinicalTrials.gov/NCT00059306